Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s share price dropped 7.9% during trading on Wednesday . The company traded as low as GBX 8 ($0.10) and last traded at GBX 8.29 ($0.11). Approximately 121,833 shares changed hands during mid-day trading, a decline of 53% from the average daily volume of 260,188 shares. The stock had previously closed at GBX 9 ($0.12).
Ondine Biomedical Stock Performance
The firm’s 50-day simple moving average is GBX 6.69 and its two-hundred day simple moving average is GBX 7.20. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37. The stock has a market capitalization of £24.74 million, a PE ratio of -312.67 and a beta of 0.10.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What Are the U.K. Market Holidays? How to Invest and Trade
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- 5 discounted opportunities for dividend growth investors
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
